Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Transplantation Proceedings

• Publication date

  1987-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 3547942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper
• Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease.

  1986cited by this paper
• Cyclosporine as prophylaxis for graft-versus-host disease: a randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia.

  1985cited by this paper
• Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.

  1985cited by this paper
• COMBINED IMMUNOSUPPRESSION WITH CYCLOSPORINE AND METHOTREXATE IN DOGS GIVEN BONE MARROW GRAFTS FROM DLA‐HAPLOIDENTICAL LITTERMATES

  1984cited by this paper
• Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings.

  1983cited by this paper
• CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE

  1982cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

  1979cited by this paper

• Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis for matched related donor hematopoietic stem cell transplantation in acute leukemia: a systematic review and meta-analysis.

  2026cites this paper
• The Impact of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Cyclosporine Concentration in Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

  2025cites this paper
• Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.

  2021cites this paper
• Long-term follow-up of a pilot study using placenta-derived decidua stromal cells for severe acute graft-versus-host disease.

  2019cites this paper
• Is day +1 omission of methotrexate associated with higher incidence of acute GvHD in hematopoietic stem cell transplantation?

  2017cites this paper
• Graft failure in the modern era of allogeneic hematopoietic SCT

  2013cites this paper
• Allogeneic transplantation: peripheral blood vs. bone marrow

  2012cites this paper
• Prevention of graft-vs.-host disease

  2012cites this paper
• Overcoming graft rejection in heavily transfused and allo‐immunised patients with bone marrow failure syndromes using fludarabine‐based haematopoietic cell transplantation

  2006cites this paper
• Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation

  2005cites this paper
• Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?

  2004cites this paper
• Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia

  2004cites this paper
• Refractory chronic GVHD emerging after splenectomy in a marrow transplant recipient with accelerated phase CML

  2003cites this paper
• Prophylaxis of graft-versus-host disease with cyclosporine–prednisone is associated with increased risk of chronic graft-versus-host disease

  2001cites this paper
• Allogeneic peripheral blood stem cell transplantation.

  2001cites this paper
• Hematopoietic Cell Transplantation: The First 50 Years and a Glimpse of the Future

  2000cites this paper
• Management of Graft-Versus-Host Disease in Paediatric Bone Marrow Transplant Recipients

  2000cites this paper
• The Development of Hematopoietic Cell Transplantation and its Application to Organ Transplantation and Autoimmune Diseases

  1999cites this paper
• Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long‐term follow‐up

  1996cites this paper
• BONE MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES AND CANCER

  1996cites this paper
• Prognostic factors affecting leukemia relapse after allogeneic BMT conditioned with cyclophosphamide and fractionated TBI.

  1996cites this paper
• Total lymphoid irradiation prior to bone marrow transplantation for severe aplastic anemia: Analysis of 20 cases

  1994cites this paper
• Die Behandlung der Aplastischen Anämie - Zielsetzung und Aufbau des Pilotprotokolls SAA 94

  1994cites this paper
• [Treatment of aplastic anemia--aims and development of the SAA 94 pilot protocol].

  1994cites this paper
• Prevention and Treatment of Acute Graft‐vs.-Host Disease

  1993cites this paper
• Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group.

  1993cites this paper
• Conditioning regimens for allogeneic bone marrow transplantation.

  1992cites this paper
• Blood transfusion in marrow graft recipients

  1992cites this paper
• Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide.

  1992cites this paper
• Bone marrow transplantation in Ramathibodi Hospital: progress report.

  1992cites this paper
• Allogeneic bone marrow transplantation: the Huddinge experience.

  1992cites this paper
• Post-remission therapy of acute myelocytic leukemia in adults: curability breeds controversy.

  1992cites this paper
• Bone marrow transplantation for acute non-lymphoblastic leukemia.

  1992cites this paper
• Response to immunization against polio after allogeneic marrow transplantation.

  1991cites this paper
• Bone marrow transplantation for metabolic disorders at Huddinge Hospital.

  1990cites this paper
• Previous donor pregnancy as a risk factor for acute graft‐versus‐host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation

  1990cites this paper
• Long-Term Comparison of Immunosuppressive Therapy with Antithymocyte Globulin to Bone Marrow Transplantation in Aplastic Anemia

  1990cites this paper
• Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.

  1990cites this paper
• Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.

  1990cites this paper
• Acute graft-versus-host disease.

  1990cites this paper
• Symptomatic cytomegalovirus infection after bone marrow transplantation

  1989cites this paper
• A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.

  1989cites this paper
• Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden.

  1989cites this paper
• Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.

  1989cites this paper
• Engraftment and transfusion requirements after allogeneic marrow transplantation for patients with acute non-lymphocytic leukemia in first complete remission.

  1989cites this paper
• Avascular necrosis of bone in bone marrow transplant patients.

  1989cites this paper
• Therapy of chronic graft-v-host disease in a rat model.

  1989cites this paper
• Early complications of bone marrow transplantation in children and adults.

  1989cites this paper
• Bone marrow transplantation: a review.

  1989cites this paper
• Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.

  1989cites this paper
• Bone marrow transplantation in children

  1989cites this paper
• Immunologic Aspects of Marrow Transplantation

  1989cites this paper
• Influence of different indwelling lines on the measurement of blood cyclosporin A levels.

  1988cites this paper
• Acute complications after bone marrow transplantation.

  1988cites this paper
• Acute Graft‐versus‐Host Disease: Clinical Characteristics in the Cyclosporine Era

  1988cites this paper
• Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse.

  1988cites this paper
• Ovarian function following marrow transplantation for aplastic anemia or leukemia.

  1988cites this paper
• Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics.

  1987cites this paper